GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Forian Inc (NAS:FORA) » Definitions » 12-1 Month Momentum %

Forian (Forian) 12-1 Month Momentum % : 11.11% (As of May. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Forian 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-20), Forian's 12-1 Month Momentum % is 11.11%.

The industry rank for Forian's 12-1 Month Momentum % or its related term are showing as below:

FORA's 12-1 Month Momentum % is ranked better than
70.42% of 649 companies
in the Healthcare Providers & Services industry
Industry Median: -13.97 vs FORA: 11.11

Competitive Comparison of Forian's 12-1 Month Momentum %

For the Health Information Services subindustry, Forian's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forian's 12-1 Month Momentum % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Forian's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Forian's 12-1 Month Momentum % falls into.



Forian  (NAS:FORA) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Forian  (NAS:FORA) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Forian 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Forian's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Forian (Forian) Business Description

Traded in Other Exchanges
N/A
Address
41 University Drive, Suite 400, Newtown, PA, USA, 18940
Forian Inc provides a suite of SaaS solutions, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators, and regulators.
Executives
Martin J Wygod director P.O. BOX 676306, RANCHO SANTA FE CA 92067
Trotman Stanley S Jr director
Max C Wygod director, officer: Executive Chairman 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Max Wygod Family Dynasty Trust 10 percent owner 41 UNIVERSITY DRIVE, SUITE 400, NEWTOWN PA 18940
Michael Vesey officer: Chief Financial Officer 4041-T HADLEY ROAD, S. PLAINFIELD NJ 07080
Jennifer Hajj director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Kristiina Md Vuori director C/O WEBMD HEALTH CORP., 111 EIGHTH AVENUE, NEW YORK NY 10011
Scott Matthew Ogur director C/O HELIX TCS, INC., 10200 E. GIRARD AVENUE, SUITE B420, DENVER CO 80231
Farren Clifford A Jr officer: Chief Financial Officer C/O SYNAVANT INC, 3445 PEACHTREE ROAD NE SUITE 1400, ATLANTA GA 30326
Adler Mark J Md director
Ian Banwell director P.O. BOX 34004, CHARLOTTE NC 28234
Shahir Kassam-adams director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Adam H Dublin director, officer: Chief Strategy Officer 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Daniel J Barton director, officer: Chief Executive Officer 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Alyssa F Varadhan director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940